RNS Number : 5351H
ValiRx PLC
25 March 2020

ValiRx Plc

("ValiRx" or the "Company")




London, UK. 25 March 2020: ValiRx Plc (AIM: VAL), a clinical stage biotechnology company, provides an update on its Notice of General Meeting ("GM"), which was due to be held today at 11:00.


Due to the current COVID-19 situation, the meeting has been adjourned until further notice.


A further announcement will be made in due course.


For more information, please contact:


ValiRx plc

Tel: +44 (0) 20 7073 2628

Dr Satu Vainikka, Chief Executive

Tel: +44 (0) 20 7073 2628

Tarquin Edwards, Head of Communications.

Tel: +44 (0) 7879 458 364


Cairn Financial Advisers LLP - Nominated Adviser


Liam Murray / Jo Turner


Tel: +44 (0) 20 7213 0880


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit